05.11.16
DSM, which continues to be a leader in peptide research, is touting Syn-Star, an innovation based on existing patented peptide technology. The enzyme PLOD3 (procollagen-lysine, 2-oxogulatarate 5-dioxygenase 3) is known to be important for the stability of intermolecular collagen crosslinks. New in-vitro tests confirmed that Syn-Star stimulates PLOD3, increasing collagen stability, specifically in mature skin, by a factor of more than 4.
According to DSM, data from recent research revealed a positive effect of Syn-Star on sebum flow. Additionally, in an invitro assay, Syn-Star was shown to inhibit DPP4, a key enzyme involved in sebum flow.
At the company’s stand (921) is the Beauty Maximizer Mask with Syn-Star 4%, niacinamide PC 4% and Pentavin 1% that NYSCC Suppliers Day visitors can take home for test drive.
According to DSM, data from recent research revealed a positive effect of Syn-Star on sebum flow. Additionally, in an invitro assay, Syn-Star was shown to inhibit DPP4, a key enzyme involved in sebum flow.
At the company’s stand (921) is the Beauty Maximizer Mask with Syn-Star 4%, niacinamide PC 4% and Pentavin 1% that NYSCC Suppliers Day visitors can take home for test drive.